ARO BIOTHERAPEUTICS Trademark

Trademark Overview

On Thursday, August 9, 2018, a trademark application was filed for ARO BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ARO BIOTHERAPEUTICS trademark a serial number of 88071501. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 12, 2022. This trademark is owned by Aro Biotherapeutics Company. The ARO BIOTHERAPEUTICS trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Manufacturing for others of pharmaceuticals and biopharmaceuticals for the treatment of diseases with high morbidity and mortality rates
aro biotherapeutics

General Information

Serial Number88071501
Word MarkARO BIOTHERAPEUTICS
Filing DateThursday, August 9, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 12, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2019

Trademark Statements

Goods and ServicesManufacturing for others of pharmaceuticals and biopharmaceuticals for the treatment of diseases with high morbidity and mortality rates
Disclaimer with Predetermined Text"BIOTHERAPEUTICS"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, May 6, 2019
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAro Biotherapeutics Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19146
Party NameAro Biotherapeutics Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19146

Trademark Events

Event DateEvent Description
Monday, September 12, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 12, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 8, 2022SOU EXTENSION 5 GRANTED
Friday, February 4, 2022SOU EXTENSION 5 FILED
Friday, February 4, 2022TEAS EXTENSION RECEIVED
Tuesday, August 31, 2021CORRECTED NOA E-MAILED
Tuesday, August 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2021DIVISIONAL PROCESSING COMPLETE
Friday, August 6, 2021DIVISIONAL REQUEST RECEIVED
Monday, August 23, 2021SOU EXTENSION 4 GRANTED
Friday, August 6, 2021SOU EXTENSION 4 FILED
Friday, August 6, 2021TEAS REQUEST TO DIVIDE RECEIVED
Friday, August 6, 2021TEAS EXTENSION RECEIVED
Wednesday, February 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 8, 2021SOU EXTENSION 3 GRANTED
Monday, February 8, 2021SOU EXTENSION 3 FILED
Monday, February 8, 2021TEAS EXTENSION RECEIVED
Wednesday, August 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2020SOU EXTENSION 2 GRANTED
Thursday, August 6, 2020SOU EXTENSION 2 FILED
Tuesday, August 18, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 6, 2020TEAS EXTENSION RECEIVED
Saturday, February 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 6, 2020SOU EXTENSION 1 GRANTED
Thursday, February 6, 2020SOU EXTENSION 1 FILED
Thursday, February 6, 2020TEAS EXTENSION RECEIVED
Tuesday, August 6, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 22, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 6, 2019ASSIGNED TO LIE
Thursday, April 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 5, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 5, 2018NON-FINAL ACTION E-MAILED
Wednesday, December 5, 2018NON-FINAL ACTION WRITTEN
Wednesday, November 28, 2018ASSIGNED TO EXAMINER
Thursday, August 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 13, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

biotherapeutics high morbidity mortality rates diseases treatment others pharmaceuticals biopharmaceuticals manufacturing